Xu Huang1, Yun Han2, Yi Shao3, Jing-Lin Yi1. 1. Affiliated Eye Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China. 2. Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute of Xiamen University, Xiamen 361102, Fujian Province, China. 3. Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Abstract
AIM: To evaluate the therapeutic effect of Nodinhibit-1 on alkali-burn-induced corneal neovascularization (CNV) and inflammation. The nucleotide-binding oligomerzation domain 1 (NOD1) is a potent angiogenic gene. METHODS: The alkali-burned rat corneas (32 right eyes) were treated with eye drops containing Nodinhibit-1 or phosphate buffered solution (PBS, PH 7.4) only, four times per day. CNV and inflammation were monitored using slit lamp microscopy, and the area of CNV was measured by formula. Vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) was determined by Western blot analysis. The TUNEL assay was used to assess the corneal apoptosis cells. RESULTS: Alkali-burn-induced progressive CNV and inflammation in the cornea. After treatment for 7d and 14d, there were statistically significant differences in the CNV areas and inflammatory index on that between two group(P<0.05, respectively). Epithelial defect quantification showed a significant difference between the two groups at days 4 and 7 after the alkali burns (P<0.05). The apoptotic cells on days 1, 4, and 7 between the two groups showed significant differences at all time points (P<0.05, respectively). Compared to that in control group, the protein level of VEGF expression was significantly reduced whereas the PEDF expression was increase in the Nodinhibit-1 groups on day 14 (P<0.05, respectively). CONCLUSION: Topical application of 10.0 µg/mL Nodinhibit-1 may have potential effect for the alkali burn-induced CNV and inflammation. The effect of Nodinhibit-1 on CNV may be by regulation the equilibrium of VEGF and PEDF in the wounded cornea.
AIM: To evaluate the therapeutic effect of Nodinhibit-1 on alkali-burn-induced corneal neovascularization (CNV) and inflammation. The nucleotide-binding oligomerzation domain 1 (NOD1) is a potent angiogenic gene. METHODS: The alkali-burned rat corneas (32 right eyes) were treated with eye drops containing Nodinhibit-1 or phosphate buffered solution (PBS, PH 7.4) only, four times per day. CNV and inflammation were monitored using slit lamp microscopy, and the area of CNV was measured by formula. Vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) was determined by Western blot analysis. The TUNEL assay was used to assess the corneal apoptosis cells. RESULTS: Alkali-burn-induced progressive CNV and inflammation in the cornea. After treatment for 7d and 14d, there were statistically significant differences in the CNV areas and inflammatory index on that between two group(P<0.05, respectively). Epithelial defect quantification showed a significant difference between the two groups at days 4 and 7 after the alkali burns (P<0.05). The apoptotic cells on days 1, 4, and 7 between the two groups showed significant differences at all time points (P<0.05, respectively). Compared to that in control group, the protein level of VEGF expression was significantly reduced whereas the PEDF expression was increase in the Nodinhibit-1 groups on day 14 (P<0.05, respectively). CONCLUSION: Topical application of 10.0 µg/mL Nodinhibit-1 may have potential effect for the alkali burn-induced CNV and inflammation. The effect of Nodinhibit-1 on CNV may be by regulation the equilibrium of VEGF and PEDF in the wounded cornea.
Authors: François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick Journal: Prog Retin Eye Res Date: 2011-11-22 Impact factor: 21.198
Authors: Francisco Amparo; Zahra Sadrai; Yiping Jin; Belen Alfonso-Bartolozzi; Haobing Wang; Hasanain Shikari; Joseph B Ciolino; James Chodosh; Ula Jurkunas; Debra A Schaumberg; Reza Dana Journal: Invest Ophthalmol Vis Sci Date: 2013-01-17 Impact factor: 4.799
Authors: Holly L Rosenzweig; Kellen T Galster; Stephen R Planck; James T Rosenbaum Journal: Invest Ophthalmol Vis Sci Date: 2008-12-13 Impact factor: 4.799
Authors: Yi Zhou; Christopher Tanzie; Zhipeng Yan; Shuyi Chen; Michael Duncan; Karin Gaudenz; Hua Li; Christopher Seidel; Brandy Lewis; Andrea Moran; Richard T Libby; Amy E Kiernan; Ting Xie Journal: Proc Natl Acad Sci U S A Date: 2013-05-15 Impact factor: 11.205
Authors: Yun Han; Mei Shen; Li-Yuan Tang; Gang Tan; Qi-Chen Yang; Lei Ye; Lin-Hong Ye; Nan Jiang; Gui-Ping Gao; Yi Shao Journal: Mol Med Rep Date: 2017-11-20 Impact factor: 2.952